Baidu
map

血气分析如何判断动脉血、静脉血?

2018-05-02 黄驰 检验在线

血气分析(BG)通过测定人体血液的H+浓度和溶解在血液中的气体(主要指CO2、O2),来了解人体呼吸功能与酸碱平衡状态的一种手段,它能直接反映肺换气功能及其酸碱平衡状态。采用的标本常为动脉血。临床上常碰到在穿刺过程中误取了静脉血标本,那么静脉血标本可以做血气分析吗?做出来的血气分析结果能反映病人的病情变化吗?能否从血气分析结果上辨别出血标本是静脉血还是动脉血呢?


编辑:湖北省中西医结合医院医学检验科   湖北省新华医院检验科

血气分析(BG)通过测定人体血液的H+浓度和溶解在血液中的气体(主要指CO2、O2),来了解人体呼吸功能与酸碱平衡状态的一种手段,它能直接反映肺换气功能及其酸碱平衡状态。采用的标本常为动脉血。临床上常碰到在穿刺过程中误取了静脉血标本,那么静脉血标本可以做血气分析吗?做出来的血气分析结果能反映病人的病情变化吗?能否从血气分析结果上辨别出血标本是静脉血还是动脉血呢?

01静脉血气的特点

静脉血气不仅能反映肺脏气体交换功能,还反映组织气体交换和机体酸碱状况。正常情况下,静脉血的 PO2 降低明显,PH 值与动脉血相近,PCO2 比动脉血略高(4-5 mmHg 左右)。但危重症患者,特别是处于循环功能衰竭的状态下动静脉血气会出现动静脉血气酸碱分离现象。这时动脉血气分析不能正确反映组织酸碱状态,而静脉血气分析才能发现严重的甚至致命的组织酸中毒。

02静脉血气值的参数

a. 静脉 PO2 正常值为 40±3 mmHg,如果混合静脉低 PO2 于 28 mmHg 常伴有乳酸酸中毒,组织灌注不足。临床上常用 28 mmHg 作为临床值。

b. 静脉正常 PCO2 值为 40~50 mmHg,与动脉 PCO2 差异不大,但在心排血量降低等情况下其结果不同。

c. 静脉 PH 正常值为 7.35~7.45,与动脉 PH 差异不大。只有病人动脉血呈低碳酸血症、呼吸性碱中毒,静脉血会呈高碳酸血症、呼吸性酸中毒,这时动脉与混合静脉血的 PH 的相差增大。

d. 静脉血氧饱和度正常值为 65%~75%。

03鉴别动静脉血气的 2 大方法

方法一:从外观上区分

动脉血颜色较鲜红,且随脉搏搏动可见注射器内液面搏动。但当病人外周循环较差时搏动不明显;严重缺氧时动脉血颜色也较深,就比较难区分了。

方法二:监测血氧饱和度

危重病人一般都有心电监测和无创氧饱和度监测(SPO2),记录抽血气时的无创氧饱和度数值,再与血气检验结果中的血氧饱和度相比较,相差 5% 以内的视为所抽血为动脉血。

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (5)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1955362, encodeId=3901195536256, content=<a href='/topic/show?id=0aeb991e44c' target=_blank style='color:#2F92EE;'>#静脉血#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=99174, encryptionId=0aeb991e44c, topicName=静脉血)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d139492, createdName=xue8602, createdTime=Wed Dec 26 18:46:00 CST 2018, time=2018-12-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1708983, encodeId=d95c1e08983a9, content=<a href='/topic/show?id=1502333250f' target=_blank style='color:#2F92EE;'>#动脉血#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=33325, encryptionId=1502333250f, topicName=动脉血)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=048f31575940, createdName=ms9833124466084992, createdTime=Sat Aug 18 03:46:00 CST 2018, time=2018-08-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1697687, encodeId=bf0a169e6874a, content=<a href='/topic/show?id=f2399910109' target=_blank style='color:#2F92EE;'>#静脉#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=99101, encryptionId=f2399910109, topicName=静脉)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0bc129907796, createdName=fusion, createdTime=Thu Feb 07 15:46:00 CST 2019, time=2019-02-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=311552, encodeId=6d20311552df, content=好文献.学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=130, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b5a62240667, createdName=张新亮1853311252142e2fm, createdTime=Thu May 03 07:25:12 CST 2018, time=2018-05-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=311394, encodeId=793231139475, content=^_^^_^^_^, beContent=null, objectType=article, channel=null, level=null, likeNumber=1, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/Swp2ehfHpiciczeTntUyQOlIGMzQ705ic67sdMTVMbwTv7KbmlUvxrGvRSvQZjPkz7ib5tEDfIaORgczPtmHDpwojg/0, createdBy=c54b2163125, createdName=wqkm, createdTime=Wed May 02 22:54:36 CST 2018, time=2018-05-02, status=1, ipAttribution=)]
    2018-12-26 xue8602
  2. [GetPortalCommentsPageByObjectIdResponse(id=1955362, encodeId=3901195536256, content=<a href='/topic/show?id=0aeb991e44c' target=_blank style='color:#2F92EE;'>#静脉血#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=99174, encryptionId=0aeb991e44c, topicName=静脉血)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d139492, createdName=xue8602, createdTime=Wed Dec 26 18:46:00 CST 2018, time=2018-12-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1708983, encodeId=d95c1e08983a9, content=<a href='/topic/show?id=1502333250f' target=_blank style='color:#2F92EE;'>#动脉血#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=33325, encryptionId=1502333250f, topicName=动脉血)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=048f31575940, createdName=ms9833124466084992, createdTime=Sat Aug 18 03:46:00 CST 2018, time=2018-08-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1697687, encodeId=bf0a169e6874a, content=<a href='/topic/show?id=f2399910109' target=_blank style='color:#2F92EE;'>#静脉#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=99101, encryptionId=f2399910109, topicName=静脉)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0bc129907796, createdName=fusion, createdTime=Thu Feb 07 15:46:00 CST 2019, time=2019-02-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=311552, encodeId=6d20311552df, content=好文献.学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=130, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b5a62240667, createdName=张新亮1853311252142e2fm, createdTime=Thu May 03 07:25:12 CST 2018, time=2018-05-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=311394, encodeId=793231139475, content=^_^^_^^_^, beContent=null, objectType=article, channel=null, level=null, likeNumber=1, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/Swp2ehfHpiciczeTntUyQOlIGMzQ705ic67sdMTVMbwTv7KbmlUvxrGvRSvQZjPkz7ib5tEDfIaORgczPtmHDpwojg/0, createdBy=c54b2163125, createdName=wqkm, createdTime=Wed May 02 22:54:36 CST 2018, time=2018-05-02, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1955362, encodeId=3901195536256, content=<a href='/topic/show?id=0aeb991e44c' target=_blank style='color:#2F92EE;'>#静脉血#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=99174, encryptionId=0aeb991e44c, topicName=静脉血)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d139492, createdName=xue8602, createdTime=Wed Dec 26 18:46:00 CST 2018, time=2018-12-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1708983, encodeId=d95c1e08983a9, content=<a href='/topic/show?id=1502333250f' target=_blank style='color:#2F92EE;'>#动脉血#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=33325, encryptionId=1502333250f, topicName=动脉血)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=048f31575940, createdName=ms9833124466084992, createdTime=Sat Aug 18 03:46:00 CST 2018, time=2018-08-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1697687, encodeId=bf0a169e6874a, content=<a href='/topic/show?id=f2399910109' target=_blank style='color:#2F92EE;'>#静脉#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=99101, encryptionId=f2399910109, topicName=静脉)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0bc129907796, createdName=fusion, createdTime=Thu Feb 07 15:46:00 CST 2019, time=2019-02-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=311552, encodeId=6d20311552df, content=好文献.学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=130, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b5a62240667, createdName=张新亮1853311252142e2fm, createdTime=Thu May 03 07:25:12 CST 2018, time=2018-05-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=311394, encodeId=793231139475, content=^_^^_^^_^, beContent=null, objectType=article, channel=null, level=null, likeNumber=1, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/Swp2ehfHpiciczeTntUyQOlIGMzQ705ic67sdMTVMbwTv7KbmlUvxrGvRSvQZjPkz7ib5tEDfIaORgczPtmHDpwojg/0, createdBy=c54b2163125, createdName=wqkm, createdTime=Wed May 02 22:54:36 CST 2018, time=2018-05-02, status=1, ipAttribution=)]
    2019-02-07 fusion
  4. [GetPortalCommentsPageByObjectIdResponse(id=1955362, encodeId=3901195536256, content=<a href='/topic/show?id=0aeb991e44c' target=_blank style='color:#2F92EE;'>#静脉血#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=99174, encryptionId=0aeb991e44c, topicName=静脉血)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d139492, createdName=xue8602, createdTime=Wed Dec 26 18:46:00 CST 2018, time=2018-12-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1708983, encodeId=d95c1e08983a9, content=<a href='/topic/show?id=1502333250f' target=_blank style='color:#2F92EE;'>#动脉血#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=33325, encryptionId=1502333250f, topicName=动脉血)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=048f31575940, createdName=ms9833124466084992, createdTime=Sat Aug 18 03:46:00 CST 2018, time=2018-08-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1697687, encodeId=bf0a169e6874a, content=<a href='/topic/show?id=f2399910109' target=_blank style='color:#2F92EE;'>#静脉#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=99101, encryptionId=f2399910109, topicName=静脉)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0bc129907796, createdName=fusion, createdTime=Thu Feb 07 15:46:00 CST 2019, time=2019-02-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=311552, encodeId=6d20311552df, content=好文献.学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=130, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b5a62240667, createdName=张新亮1853311252142e2fm, createdTime=Thu May 03 07:25:12 CST 2018, time=2018-05-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=311394, encodeId=793231139475, content=^_^^_^^_^, beContent=null, objectType=article, channel=null, level=null, likeNumber=1, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/Swp2ehfHpiciczeTntUyQOlIGMzQ705ic67sdMTVMbwTv7KbmlUvxrGvRSvQZjPkz7ib5tEDfIaORgczPtmHDpwojg/0, createdBy=c54b2163125, createdName=wqkm, createdTime=Wed May 02 22:54:36 CST 2018, time=2018-05-02, status=1, ipAttribution=)]
    2018-05-03 张新亮1853311252142e2fm

    好文献.学习了

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1955362, encodeId=3901195536256, content=<a href='/topic/show?id=0aeb991e44c' target=_blank style='color:#2F92EE;'>#静脉血#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=99174, encryptionId=0aeb991e44c, topicName=静脉血)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d139492, createdName=xue8602, createdTime=Wed Dec 26 18:46:00 CST 2018, time=2018-12-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1708983, encodeId=d95c1e08983a9, content=<a href='/topic/show?id=1502333250f' target=_blank style='color:#2F92EE;'>#动脉血#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=33325, encryptionId=1502333250f, topicName=动脉血)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=048f31575940, createdName=ms9833124466084992, createdTime=Sat Aug 18 03:46:00 CST 2018, time=2018-08-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1697687, encodeId=bf0a169e6874a, content=<a href='/topic/show?id=f2399910109' target=_blank style='color:#2F92EE;'>#静脉#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=99101, encryptionId=f2399910109, topicName=静脉)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0bc129907796, createdName=fusion, createdTime=Thu Feb 07 15:46:00 CST 2019, time=2019-02-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=311552, encodeId=6d20311552df, content=好文献.学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=130, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b5a62240667, createdName=张新亮1853311252142e2fm, createdTime=Thu May 03 07:25:12 CST 2018, time=2018-05-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=311394, encodeId=793231139475, content=^_^^_^^_^, beContent=null, objectType=article, channel=null, level=null, likeNumber=1, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/Swp2ehfHpiciczeTntUyQOlIGMzQ705ic67sdMTVMbwTv7KbmlUvxrGvRSvQZjPkz7ib5tEDfIaORgczPtmHDpwojg/0, createdBy=c54b2163125, createdName=wqkm, createdTime=Wed May 02 22:54:36 CST 2018, time=2018-05-02, status=1, ipAttribution=)]
    2018-05-02 wqkm

    ^_^^_^^_^

    0

相关资讯

详解“血气分析”,每个医生都要会

导读:血气分析可以了解氧气的供应和酸碱平衡状况,是抢救危重病人和手术中监护的重要指标之一。有采自于动脉和静脉血两种,但静脉血不能反映氧和情况,临床上常用动脉血。

快速上手之血气分析七步法

血气分析在呼吸科是一项非常常用的检测项目,其测定结果可为心、肺疾病和各种危重疾病患者提供诊断和治疗的依据。所以每个呼吸科医生都应该全面掌握血气分析结果的判断。

血气分析超完备攻略!

一   血气分析有何作用?1、血气分析是衡量呼吸衰竭的客观指标根据血气分析可将呼吸衰竭分为Ⅰ型呼吸衰竭和Ⅱ型呼吸衰竭。标准:①海平面平静呼吸空气条件下:●Ⅰ型呼吸衰竭:PaO2<60mmHg  PaCO2正常或下降;●Ⅱ型呼吸衰竭:PaO2<60mmHg  PaCO2>50mmHg 。②吸O2条件下判断有无呼吸衰竭可见于以下两种情况:● 若PaCO2>50mmHg

血气分析| 影响结果的7大因素

动脉血气分析是对危重症患者的重要实验室检测手段之一,对诊疗方案的制定有着重要指导意义。世界卫生组织(WHO)将整个检验过程分成分析前、分析中、分析后三个阶段。其中,标本分析前阶段是一个最复杂的过程,因为和分析中或分析后阶段比,分析前阶段(包括从检验申请、患者准备和识别、样本采集、储藏运输等)有最多的人为随机因素可造成误差,也不像机器可通过常规质控措施及时发现[1]。动脉血是临床实验室中最为敏感

BMJ Open:COPD患者预后相关因素

研究组进行了一项研究,探究高碳酸血症能否预测慢性阻塞性肺疾病(COPD)的预后。该前瞻性队列研究共纳入了275名40-85岁稳定期COPD患者(不包含影响 PaCO2 相关并发症的患者如阻塞性睡眠呼吸暂停症、肥胖引起的肺换气不足或神经肌肉疾病),通过血气分析检测血碳酸情况,比较了不同血碳酸含量COPD患者的生存,其中血碳酸含量正常的有98人,高于正常的慢性高碳酸血症有177人。研究数据显示,血碳酸

Baidu
map
Baidu
map
Baidu
map